On the 27 of November, Prime Minister Muhyiddin Yassin had announced that a preliminary deal had been signed between the Malaysian Government and US drug maker Pfizer to supply the vaccine for Covid-19. The company had co-developed the vaccine with BioNTech, a company based in Germany had the results of their product had shown an efficiency rate above 90%.
In the deal made between the government and Pfizer, we will be receiving a total of 12.8 million doses. 1 million doses of the vaccine will be delivered during the first quarter of 2021 followed by 1.7 million, 5.8 million and 4.3 million according to each subsequent quarter.
Datuk Seri Muhyiddin stated that 12.8 million doses can cater to 20% of our population which is about 6.4 million Malaysians as of now. Malaysians will not need to pay for the vaccine (yes it’s free for us!) but foreigners will need to purchase it for themselves. There has been no exact announcement on how much the vaccine will cost as it has yet to be determined by the Ministry of Health (MoH).
The vaccine will be prioritized for those who are front liners, elderly and patients with serious diseases. The US Food and Drugs Administration as well as Malaysia’s own National Pharmaceutical Regulatory Agency has yet to approve of the vaccine hence distribution will be subjected to the approval from them.